Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Blue skeletal formula on white background. | |
Licence : | Libre de droits |
Crédit: | Science Photo Library / Molekuul |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |